fbpx
CALL US: 210-949-0122
Continuing COVID-19 vaccine work - Sign up for future studies »
Douglas Denham, DO, CPI

Douglas Denham, DO, CPI

Chief Medical Director

Douglas Scott Denham, DO, CPI is Chief Medical Director of Clinical Trials of Texas, Inc. (CTT) and is board-certified in family medicine, with more than 25 years of experience. He has served as Principal Investigator on more than 500 studies in the areas of diabetes, fatty liver, healthy volunteers, hyperlipidemia, seasonal allergies, vaccines, growth hormone, diabetic peripheral neuropathy, implantable devices, insulin pumps, clamp studies, renal studies and more. His experience includes Phase I-IV protocols, including first-in-man studies.

At the University of North Texas Health Science Center, Texas College of Osteopathic Medicine,             Dr. Denham earned his Doctoral degree in Osteopathic Medicine. He completed his residency at the University of Texas Health Science Center at San Antonio.

Dr. Denham was honored as an Outstanding Medical Researcher in 2018 by the San Antonio Business Journal and in 2019 for Outstanding Leadership in Clinical Research by a Principal Investigator Award by the Association of Clinical Research Professionals (ACRP).